SciRhom raises €7.0M Seed round

To advance the company's first-in-class TACE antagonists into the clinic for autoimmune and other indications.

Source: https://www.scirhom.com/news-press/2019/12/scirhom-completes-seed-financing-round-to-advance-first-in-class-tace-antagonists-into-the-clinic